Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02752997 · ClinicalTrials.gov registry record · NA
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02752997: Completed NA study, sponsored by Mayo Clinic.
NCT02752997 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02752997, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.
Interventions
- OTHER Pharmacist discharge medication services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02752997
The ClinicalTrials.gov registry entry for NCT02752997 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist discharge medication services is the first listed.
NCT02752997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02752997 about?
NCT02752997 is a clinical study titled "Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services". Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.
What is the current status of trial NCT02752997?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02752997?
The interventions under investigation include: Pharmacist discharge medication services (OTHER).
Who is sponsoring clinical trial NCT02752997?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.